Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ALX-804-099-R100 - Provider product page
- Provider
- Enzo Life Sciences
- Proper citation
- Enzo Life Sciences Cat#ALX-804-099-R100, RRID:AB_2051868
- Product name
- Mineralocorticoid (aldosterone) receptor monoclonal antibody (H10E4C9F)
- Antibody type
- Monoclonal
- Antigen
- Other
- Description
- Protein A-affinity purified.
- Reactivity
- Human, Rat, Chicken/Avian, Rabbit
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- H10E4C9F
- Vial size
- 100 μl
- Storage
- -20°C
- Handling
- Avoid freeze/thaw cycles.
Submitted references Pituitary expression of type I and type II glucocorticoid receptors during chicken embryonic development and their involvement in growth hormone cell differentiation.
Identification of glucocorticoid receptor domains involved in transrepression of transforming growth factor-beta action.
The mineralocorticoid receptor may compensate for the loss of the glucocorticoid receptor at specific stages of mammary gland development.
Prerequisite for cardiac aldosterone action. Mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase in the human heart.
Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor.
Aldosterone antagonists destabilize the mineralocorticosteroid receptor.
Immunohistochemical localization of renal mineralocorticoid receptor by using an anti-idiotypic antibody that is an internal image of aldosterone.
Internal image properties of a monoclonal auto-anti-idiotypic antibody and its binding to aldosterone receptors.
Bossis I, Nishimura S, Muchow M, Porter TE
Endocrinology 2004 Jul;145(7):3523-31
Endocrinology 2004 Jul;145(7):3523-31
Identification of glucocorticoid receptor domains involved in transrepression of transforming growth factor-beta action.
Li G, Wang S, Gelehrter TD
The Journal of biological chemistry 2003 Oct 24;278(43):41779-88
The Journal of biological chemistry 2003 Oct 24;278(43):41779-88
The mineralocorticoid receptor may compensate for the loss of the glucocorticoid receptor at specific stages of mammary gland development.
Kingsley-Kallesen M, Mukhopadhyay SS, Wyszomierski SL, Schanler S, Schütz G, Rosen JM
Molecular endocrinology (Baltimore, Md.) 2002 Sep;16(9):2008-18
Molecular endocrinology (Baltimore, Md.) 2002 Sep;16(9):2008-18
Prerequisite for cardiac aldosterone action. Mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase in the human heart.
Lombès M, Alfaidy N, Eugene E, Lessana A, Farman N, Bonvalet JP
Circulation 1995 Jul 15;92(2):175-82
Circulation 1995 Jul 15;92(2):175-82
Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor.
Lombès M, Oblin ME, Gasc JM, Baulieu EE, Farman N, Bonvalet JP
Circulation research 1992 Sep;71(3):503-10
Circulation research 1992 Sep;71(3):503-10
Aldosterone antagonists destabilize the mineralocorticosteroid receptor.
Couette B, Lombes M, Baulieu EE, Rafestin-Oblin ME
The Biochemical journal 1992 Mar 15;282 ( Pt 3):697-702
The Biochemical journal 1992 Mar 15;282 ( Pt 3):697-702
Immunohistochemical localization of renal mineralocorticoid receptor by using an anti-idiotypic antibody that is an internal image of aldosterone.
Lombès M, Farman N, Oblin ME, Baulieu EE, Bonvalet JP, Erlanger BF, Gasc JM
Proceedings of the National Academy of Sciences of the United States of America 1990 Feb;87(3):1086-8
Proceedings of the National Academy of Sciences of the United States of America 1990 Feb;87(3):1086-8
Internal image properties of a monoclonal auto-anti-idiotypic antibody and its binding to aldosterone receptors.
Lombes M, Edelman IS, Erlanger BF
The Journal of biological chemistry 1989 Feb 15;264(5):2528-36
The Journal of biological chemistry 1989 Feb 15;264(5):2528-36
No comments: Submit comment
No validations: Submit validation data